XOMA Royalty (XOMA) Current Assets (2010 - 2026)
XOMA Royalty (XOMA) reported Current Assets of $118.7 million for Q1 2026, up 4.88% on a YoY basis from $113.2 million in Q1 2025, and up 1.27% sequentially from $117.3 million in Q4 2025.
XOMA Royalty (XOMA) Current Assets (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Current Assets data on file, last reported at $118.7 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 4.88% year-over-year to $118.7 million; the trailing twelve-month figure through Mar 2026 stood at $118.7 million (up 4.88% YoY), and the FY2025 full-year result was $117.3 million, down 6.64% from the prior year.
- Current Assets climbed to $118.7 million in Q1 2026, from $117.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $169.3 million in Q4 2023 to a low of $34.5 million in Q3 2023.
- A 5-year average of $103.3 million and a median of $109.1 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets slumped 56.73% in 2023 and soared 360.86% in 2024, its largest moves.
- Tracing XOMA's Current Assets over 5 years: stood at $61.3 million in 2022, then jumped by 176.42% to $169.3 million in 2023, then decreased by 25.82% to $125.6 million in 2024, then dropped by 6.64% to $117.3 million in 2025, then rose by 1.27% to $118.7 million in 2026.
- Business Quant data shows XOMA's Current Assets at $118.7 million in Q1 2026, $117.3 million in Q4 2025, and $104.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 118.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.75 Mn |
| Dec 31, 2025 | 117.26 Mn |
| Jun 30, 2025 | 104.93 Mn |
| Mar 31, 2025 | 113.23 Mn |
| Dec 31, 2024 | 125.60 Mn |
| Sep 30, 2024 | 159.02 Mn |
| Jun 30, 2024 | 162.20 Mn |
| Mar 31, 2024 | 146.89 Mn |
| Dec 31, 2023 | 169.31 Mn |
| Sep 30, 2023 | 34.51 Mn |
| Jun 30, 2023 | 38.42 Mn |
| Mar 31, 2023 | 45.07 Mn |
| Dec 31, 2022 | 61.25 Mn |
| Sep 30, 2022 | 79.74 Mn |
| Jun 30, 2022 | 87.26 Mn |
| Mar 31, 2022 | 89.61 Mn |
| Dec 31, 2021 | 96.97 Mn |
| Sep 30, 2021 | 74.87 Mn |
| Jun 30, 2021 | 87.25 Mn |
| Mar 31, 2021 | 70.25 Mn |